News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Johnson Laura L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2022 |
4
| Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Disposed/sold 500 shares
@ $6.23, valued at
$3.1k
Disposed/sold 13,500 options to buy
@ $6, valued at
$81k
Disposed/sold 13,000 options to buy
@ $10.84, valued at
$140.9k
Disposed/sold 10,000 options to buy
@ $19.69, valued at
$196.9k
Disposed/sold 10,000 options to buy
@ $28.24, valued at
$282.4k
Disposed/sold 10,000 options to buy
@ $19.19, valued at
$191.9k
Disposed/sold 10,000 options to buy
@ $28.1, valued at
$281k
Disposed/sold 12,000 options to buy
@ $5.99, valued at
$71.9k
Disposed/sold 12,000 options to buy
@ $3.93, valued at
$47.2k
Disposed/sold 30,000 options to buy
@ $4.53, valued at
$135.9k
Disposed/sold 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2022 |
4
| Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.81, valued at
$144.3k
|
|
| 11/24/2021 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $0.7423, valued at
$2.2k
|
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2020 |
4
| Johnson Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 30,000 options to buy
@ $4.53, valued at
$135.9k
|
|
| 12/10/2020 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.52, valued at
$247.8k
|
|
| 09/17/2020 |
4
| Johnson Laura L. (Director) has filed a Form 4 on Kintara Therapeutics, Inc.|
Txns:
| Granted 120,000 options to buy
@ $1.7, valued at
$204k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2019 |
4
| Douglass Laura L. (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $30.51, valued at
$381.4k
|
|
| 01/25/2019 |
4
| Douglass Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 12,000 options to buy
@ $5.99, valued at
$71.9k
|
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| Douglass Laura L. (Director) has filed a Form 4 on Odonate Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $15.79, valued at
$552.7k
|
|
| 06/01/2018 |
4
| Douglass Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Exercised 500 options to buy
@ $6, valued at
$3k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2017 |
4
| Douglass Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 10,000 options to buy
@ $28.1, valued at
$281k
|
|
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/23/2015 |
4
| Douglass Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
| 02/25/2015 |
4
| Douglass Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 10,000 options to buy
@ $19.69, valued at
$196.9k
|
|
| 04/07/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/26/2013 |
4
| Douglass Laura L. (Director) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO|
Txns:
| Granted 900,000 options to buy
@ $0.12, valued at
$108k
|
|
|
|